Blasetti A, Faille A, Balitrand N, Gluckman E, Devergie A, Dresch C
J Clin Pathol. 1982 Dec;35(12):1316-9. doi: 10.1136/jcp.35.12.1316.
The inhibitory activity of peripheral blood lymphocytes on autologous bone marrow was studied in 27 patients with aplastic anaemia after treatment with androgen. Inhibitory activity was hard to assess in 10 patients studied during the first year of treatment. The colony count was too low to be certain of differences between the samples incubated with or without lymphocytes. Among the 17 patients who had more than 10 colonies per 2 x 10(5) mononuclear bone marrow cells, nine showed inhibitory activity by peripheral blood lymphocytes. After 12 months of androgen therapy each of these patients showing inhibitory activity of bone marrow colony forming cells by peripheral lymphocytes responded to antithymocyte globulin. None of nine patients with few colony forming cells or no inhibitory activity of lymphocytes responded to immunosuppression.
对27例接受雄激素治疗后的再生障碍性贫血患者外周血淋巴细胞对自体骨髓的抑制活性进行了研究。在治疗第一年研究的10例患者中,抑制活性难以评估。集落计数过低,无法确定与有或无淋巴细胞孵育的样本之间的差异。在每2×10⁵个单核骨髓细胞中有超过10个集落的17例患者中,9例显示外周血淋巴细胞具有抑制活性。雄激素治疗12个月后,这些外周淋巴细胞显示骨髓集落形成细胞具有抑制活性的患者均对抗胸腺细胞球蛋白有反应。9例集落形成细胞少或淋巴细胞无抑制活性的患者均未对免疫抑制产生反应。